Adage Capital Partners’s Assembly Biosciences ASMB Stock Holding History

Adage Capital Partners’s Portfolio ASMB Stock Details ASMB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.47M	Hold	161,000	–	–	0.01%	781
2025 Q4	$5.48M	Buy	+161,000	New	+$5.19M	0.01%	752
2020 Q1	–	Sell	-6,458	Closed	-$1.59M	–	730
2019 Q4	$1.59M	Buy	+6,458	New	+$1.19M	﹤0.01%	665
2019 Q2	–	Sell	-6,250	Closed	-$1.48M	–	703
2019 Q1	$1.48M	Hold	6,250	–	–	﹤0.01%	653
2018 Q4	$1.7M	Hold	6,250	–	–	﹤0.01%	666
2018 Q3	$2.79M	Sell	6,250 -10,417	-63%	-$4.88M	0.01%	665
2018 Q2	$7.84M	Buy	16,667 +2,084	+14%	+$1.1M	0.02%	602
2018 Q1	$8.6M	Hold	14,583	–	–	0.02%	581
2017 Q4	$7.92M	Buy	+14,583	New	+$6.6M	0.02%	594

Other funds holding ASMB

Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PHP

Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Adage Capital Partners's ASMB Position: Q1 2026 in Review

Adage Capital Partners held its Assembly Biosciences (ASMB) position steady in Q1 2026 at 161,000 shares worth $4.47M. The position accounts for 0.01% of the portfolio, ranked #781.

Adage Capital Partners first reported a position in ASMB in Q4 2017 and has held it in 9 quarters since. The position peaked at $8.6M in Q1 2018. 75 funds tracked by Wall St. Rank hold ASMB as of Q1 2026.

Adage Capital Partners held 161,000 shares of Assembly Biosciences worth $4.47M as of Q1 2026.
Adage Capital Partners left its Assembly Biosciences share count unchanged in Q1 2026.
Assembly Biosciences made up 0.01% of Adage Capital Partners's portfolio in Q1 2026, its #781 holding.
Adage Capital Partners first reported a position in Assembly Biosciences in Q4 2017 and has held it in 9 quarters since.
Adage Capital Partners's Assembly Biosciences position peaked at $8.6M in Q1 2018.
75 funds tracked by Wall St. Rank held Assembly Biosciences as of Q1 2026.

Based on Adage Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.